Semaglutide: A Dual Benefit for Diabetes and Weight Management in American Men
Reading Time: 2 minutes Introduction to Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a significant advancement in the management of type 2 diabetes. As a once-weekly injectable medication, it offers a convenient option for patients, aligning well with the demands of busy American lifestyles. General practitioners are increasingly recognizing semaglutide's potential not only in glycemic control but also in weight management, making it a versatile tool in primary care settings. Mechanism of Action Semaglutide mimics the incretin hormone GLP-1, which is naturally released in response to food intake. By binding to GLP-1 receptors, semaglutide enhances insulin secretion, suppresses glucagon release,...



